LUCKY cement hasnt published their CBS slides till now ?

FFBL will be conducting CBS tomorrow

Can a laborer , plumber , Technician , open account in almeezan ( without being pushed to pay Front end load or avail pension benefit) - high time we realize our gate keeping is not helping

Stay away from TPL REIT - just a scheme to avoid taxes for the elites - nothing more , if you still find value in it - then for sure go ahead

The upcoming IPO by Arif Habib Limited looks interesting

Full disclosure - i have been doing profit taking on EFERT

From inventory gains - currency gains to inventory losses currency losses - PSX aint that difficult

Foreign stake in PSX hasn't drastically changed

Invest Kar Do Can’t agree more. #EFERT had that bad quarter during 2022. Those who grabbed that opportunity must have been extremely happy with cashflow it is generating. #SYS buyer will celebrate the same in next two years or even earlier.

$DCR occupancy percentage is still 97 %
Market footfall around 22 -23 K daily
Rental income increased from 3.12 to 3.61 B Rs

the good news is not the best of quarters for TOMCL - however gross profits are up , lesser currency gain EPS dropped

in ko apni company hi baichna nahi aati - bhai scale to sahi rakhtay $DCR

SYS results not so good this quarter but this is good news

Invest Kar Do Highnoon is to pharma what MTL is to engineering.

Good management with sensible growth over time.

Both Lahore based

💸💰 Everything you need to know about corporate finance 👇:

🔸Uses of financing: All companies have assets that are used to generate cash. The assets side of a balance sheet records these.

🔸Sources of financing: On the other side, a balance sheet records financing. This is…

for Reviewing PSO this financial statement is not enough we need to wait for the quarterly report nad see the trade debt .

Financial cost has increasd to 40B for the first nine months of FY 24

$highnoon is one of the most underrated pharma share listed in PSX . YOY improvement in top line

You can see the drop in valuation ( PE ratio ) and increase in div yield %

Second largest pharma cap in PSX